drugset / Trial / NCT00430794
The Efficacy of Spironolactone in Patients With Resistant Hypertension
Phase 2
Terminated
40 enrolled
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
To determine the efficacy of the addition of spironolactone to modern blood pressure lowering treatment regimens in patients with resistant hypertension (whose blood pressure is uncontrolled despite three blood pressure lowering drugs)
Timeline
- Start
- 2007-03
- Primary completion
- —
- Completion
- 2008-12
Outcome
Outcome not reported
Stopped (Enrollment): “Difficulties with recruitment.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Spironolactone | Small molecule | 50 mg | — |